Respiratory Mechanics Measurement of Ventilated Patients Through Low-frequency Oscillometry Technique
1 other identifier
interventional
21
1 country
1
Brief Summary
Respiratory failure has historically been one of the most important causes for admittance of patients to the critical care unit. This problem was the most important reason during the COVID-19 pandemic. Following the evolution of the physiology of the lung has therefore been the number one concern during these challenging times in the intensive care unit (ICU). Respiratory oscillometry (RO) identifies the lung impedance by applying small pressure oscillations onto the breathing or ventilation. Information about the respiratory mechanics can be extracted out of this impedance, including the resistance (R) and compliance (C) of the lung. The VUB developed a robust, patient safe RO measurement protocol that delivers high quality measurements with the least possible interference with the patient's breathing/ventilation. The technique challenges current state-of-the-art techniques also aiming at identifying R and C of the respiratory system (not exclusively RO). The RO measurement protocol is in line with the technical standards of the ERS (European Respiratory Society) and has been successfully and safely tested on emulators and some parts on test subjects. The clinical investigation aims at a powered equivalence investigation between the RO measurement protocol and a standard of care dynamic compliance estimate on invasive ventilated patients. As secondary objectives, the feasibility of the RO techniques will be investigated during pressure support ventilation and the RO estimates will also be compared with other accepted respiratory mechanics estimation tools. To enable the investigation, a RO algorithm is developed, and a RO measurement extension is implemented in the DemcAir® ventilation system of Demcon. This was a fully tested ventilator that received a CE mark under the previous MDD regulation. However, Demcon, which produces ventilator parts for other commercial partners, removed the label to avoid competition with their partners. The ventilator will only execute the protocol on demand and save the data on an USB stick available in the ventilator. At any time, the RO measurement procedure can be stopped, and the ventilator will return to its initial ventilation. The USB stick is used to transport the data to a separate (VUB) laptop where the data processing is done.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 18, 2023
CompletedFirst Submitted
Initial submission to the registry
September 27, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 3, 2024
June 1, 2024
1 year
September 27, 2023
July 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
compliance
compliance of the lung expressed in "ml/cmH20 "
Twice a day with at least 4hour interval, during 1 hour, compliance will be measured in every interventional action: ROELEC protocol, SOTA, dynamic P/V curve and low flow P/V curve
Secondary Outcomes (2)
resistance
Twice a day with at least 4hour interval, during 1 hour, resistance will be measured in every interventional action: ROELEC protocol, SOTA, dynamic P/V curve and low flow P/V curve
impedance
Twice a day with at least 4hour interval, during 1 hour, impedance will be measured in every interventional action: ROELEC protocol, SOTA, dynamic P/V curve and low flow P/V curve
Study Arms (4)
ROELEC PROTOCOL
EXPERIMENTALROELEC measurements consist of the application of a sine or multisine excitation pressure signal superimposed on the ventilation signal. The novelties are in the smart design of the excitation signal, not the way it is applied to the patient.
dynamic P/V curves
ACTIVE COMPARATORdynamic ventilatory pressure volume curves generated during the standard ventilation settings
low flow P/V curves
OTHERstatic ventilatory pressure volume curves will be generated during the procedure to assure that the patients ventilation is between the lower inflection point and the higher inflection point. this P/V curves will also be analysed but will not be included in the primary endpoint analysis
SOTA
OTHERStandard of care oscillometry protocol will also generate low flow P/V curves but will not be included in the primary endpoint analysis
Interventions
compliance can be measured by analyzing pressure volume curves generated through different methods
Eligibility Criteria
You may qualify if:
- intubation
- Controlled ventilation with an intention to continue controlled ventilation for the following 4 hours.
- Richmond agitation sedation scale of -4 or less
- Hemodynamically stable patient with either
- unchanged vasopressor dose administration for at least 60 minutes before the start of the measurements
- no vasopressor need and no vasopressor initiated within 60 minutes of measurements
- No planned intervention in the coming 2 hours
- Survival for at least 48 hours
- Protective ventilation (inspired oxygen concentration≤60%, plateau pressure ≤30 cmH2O , driving pressure≤ 15cmH2O)
- PEEP (Positive End Expiratory Pressure) ≤10
You may not qualify if:
- assist ventilation
- Ventilator asynchronies
- Intermittent spontaneous breathing
- nitric oxide therapy
- presence of an extra corporeal membrane oxygenation device
- Ventilation is not possible within the lower and upper inflection point of the low flow pressure volume curve.
- Unstable right heart failure
- Unstable lung embolism
- Standard of care without Sedline® or invasive arterial catheter
- Do not reanimate code of 2, 3 or 4
- Subjects who are healthy, minors, pregnant women, patients in emergency situation
- Outside the age range 18 to 84 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, Brussel Hoofstedelijk Gewest, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
joop jonckheer, MD, PhD
Universitair Ziekenhuis Brussel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2023
First Posted
July 3, 2024
Study Start
September 18, 2023
Primary Completion
September 30, 2024
Study Completion
December 31, 2024
Last Updated
July 3, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- after the most important manuscript(s) will be published, data will be shared. however upon request for review of the manuscript data can be shared.
- Access Criteria
- after the most important manuscript(s) will be published, data will be shared. however upon request for review of the manuscript data can be shared.
The Clinical Trial Summary Excel file and the .mat files can be shared safely on a request basis, given the anonymization scheme. This will allow other researchers to run their processing on the dataset and reach their own conclusions. The GDPR additional Excel file, or Mapping Table, and the eCRF will never be shared with anyone outside the principal investigator/authorized study member. With it, anyone can identify the patients who took part in the clinical trial.